Cardiovascular and Interventional Radiological Society of Europe

September 10-14 | Barcelona, Spain

September 10-14 | Barcelona, Spain

September 10-14 | Barcelona, Spain

September 10-14 | Barcelona, Spain

September 10-14 | Barcelona, Spain

Slider
AboutAwards and honoursCVIR Editors’ Medal

CVIR Editors’ Medal

At CIRSE 2022, Prof. Mark Little was awarded the CVIR Editors’ Medal for the paper “Genicular artEry embolizatioN in patiEnts with oSteoarthrItiS of the Knee (GENESIS) Using Permanent Microspheres: Interim Analysis”.

Mark Little
Mark Little
CVIR Editors' Medallist
(Reading/UK)

Professor Little initially read physics at university, training as a medical physicist specialising in MRI, nuclear medicine, and radiotherapy. With an ever-growing fascination for radiology, he attended medical school, qualifying with distinction prior to medical and surgical rotations in Cambridge, UK. In 2011, he was awarded the highly regarded National Institute for Health Research (NIHR) Academic Clinical Fellowship (ACF) in Clinical Radiology at Oxford.

Professor Little is currently a consultant interventional radiologist and research lead within the University Department of Radiology, Royal Berkshire NHS Foundation Trust, Reading, UK. He is actively involved in teaching and research, has led numerous research studies, holds several research grants, and has established a large embolotherapy research group alongside his busy IR clinical practice. In 2013, Professor Little travelled to Lisbon to learn about Prostate Artery Embolisation (PAE) under the guidance of Professor Pisco. On his return to the UK, Professor Little successfully gained grant funding from the Royal College of Radiologists to commence the STREAM study investigating the effectiveness of PAE in the treatment of benign prostatic hyperplasia (BPH). He is currently UK Chief Investigator for PROstate, an international study investigating long-term outcomes of PAE.

Professor Little is recognized internationally for his research into Genicular Artery Embolisation (GAE), having led the first European study investigating GAE in the treatment of knee OA (GENESIS).  Prof Little has lectured and published widely on GAE. His research group are currently investigating the role of neuropsychological traits to predict clinical success in patients with knee OA following GAE, and are soon to commence GENESIS 2, a sham randomized controlled trial investigating the clinical effectiveness of GAE in patients with mild to moderate knee OA.

In 2018 Professor Little was awarded the NIHR research rising star award and in 2022 The CARE award for innovation and research.  Professor Little is a Fellow of the Higher Education Academy (FHEA), visiting Professor at the University of Reading, and specialist advisor for the National Institute for Health and Care Excellence (NICE) Interventional Procedures Program for embolotherapy.